Related Experiment Video

Updated: Oct 19, 2025

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

5.9K

Living with hypertrophic cardiomyopathy: a patient's perspective

Wendy Borsari1,2, Lindsay Davis3,2, Eric Meiers4,2

  • 1Medical consultant, HCM patient, Plymouth, MA 02360, USA.

Future Cardiology
|September 17, 2021
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) is a complex heart muscle disease. Patient stories reveal diagnostic and symptom management challenges, emphasizing the need for better understanding to improve quality of life.

Area of Science:

  • Cardiology
  • Genetics
  • Patient Advocacy

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart muscle disease causing thickening of the cardiac walls.
  • Symptoms like chest pain, shortness of breath, and fainting are common but often misdiagnosed.
  • Current treatments focus on symptom relief, with surgery for severe cases, yet the patient experience is under-documented.

Purpose of the Study:

  • To highlight the humanistic burden of HCM through patient testimonials.
  • To illustrate the challenges in diagnosing and managing HCM symptoms.
  • To inform disease diagnosis, monitoring, and improve patient outcomes.

Main Methods:

  • Presentation of four anonymized patient testimonials.
  • Qualitative analysis of patient experiences across generations.
  • Focus on diagnostic and symptomatic management challenges.

Main Results:

  • Testimonials reveal significant difficulties in achieving accurate HCM diagnosis.
  • Patient narratives underscore the variability and impact of symptoms on daily life.
  • Insights into the generational spectrum and expression of HCM were shared.

Conclusions:

  • Patient testimonials offer crucial insights into the lived experience of HCM.
  • Addressing diagnostic and management challenges can improve patient quality of life.
  • Understanding the humanistic burden is key to optimizing HCM care and outcomes.

Keywords:
hypertrophic cardiomyopathyimplantable cardioverter defibrillatorpatient experienceseptal myectomy

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.8K
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.2K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
96
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
67
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
77
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
78
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
59
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
105